Foamix于2003年1月19号在以色列成立。该公司是一家临床阶段制药公司专注于开发和商业化公司专有的泡沫米诺环素治疗痤疮,脓疱疮等皮肤状况。该公司的主导候选产品,fmx101为中度至重...查看全文
牛唐2018-07-28 22:07
$Foamix(FOMX)$ FMX101是外用的minocyline,用于治疗痤疮,预计今年下半年或明年上半年申报NDA,如果获批的话,将是首个获批的米诺环素外用药查看全文
$Foamix(FOMX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-01-28 AccNo: 0001178913-15-000214 Size: 89 KB 网页链接
$Foamix(FOMX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-01-28 AccNo: 0001178913-15-000212 Size: 97 KB 网页链接
$Foamix(FOMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2014-12-29 AccNo: 0001178913-14-003946 Size: 22 KB 网页链接
$Foamix(FOMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2014-11-24 AccNo: 0001178913-14-003671 Size: 206 KB 网页链接
$Foamix(FOMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2014-11-13 AccNo: 0001178913-14-003538 Size: 306 KB 网页链接
$Foamix(FOMX)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2014-10-21 AccNo: 0001567619-14-000525 Size: 182 KB 网页链接
$Foamix(FOMX)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2014-09-18 AccNo: 0001567619-14-000472 Size: 18 KB 网页链接
$Foamix(FOMX)$ F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)] Filed: 2014-09-17 AccNo: 0001567619-14-000470 Size: 454 KB 网页链接
$Foamix(FOMX)$ F-1/A [Amend] - Registration statement for certain foreign private issuers Filed: 2014-09-03 AccNo: 0001567619-14-000434 Size: 5 MB 网页链接
$Foamix(FOMX)$ EFFECT - Notice of Effectiveness Filed: 2014-09-17 AccNo: 9999999995-14-002798 Size: 1 KB 网页链接